Nutrisense vs Signos: Which Is Better in 2026?

Start with your goal, because these platforms are built for different ones. If your primary aim is weight loss, Signos is the more targeted tool: it carries FDA-cleared weight management claims, uses AI to prompt things like exercise timing in response to your glucose, and explicitly supports people on GLP-1 medications like Ozempic and Wegovy. If your aim is broader — understanding your metabolism, managing blood sugar, building better eating habits with expert help — Nutrisense is the stronger platform, pairing Abbott Libre sensors with registered dietitian consultations that no AI coach fully replaces. Price won't settle it for you: Nutrisense runs $225–399/month and Signos $199–399/month with a 3-month commitment, so both are significant ongoing investments. Our general lean is Nutrisense for most readers, simply because human dietitian guidance is the rarer and more broadly useful asset. But for a goal-oriented dieter — especially one already on a GLP-1 — Signos' narrower focus is a feature, not a limitation.

The daily experience diverges around coaching style. Nutrisense is conversational and human-paced: you log meals, your registered dietitian reviews the data, and guidance arrives as considered, personalized advice. It feels like working with a professional — thoughtful, accountable, but not instant.

Signos is real-time and machine-paced. Its AI coaching reacts to your glucose as it moves — nudging you toward things like a walk when your levels suggest the timing is right. For weight-loss users this immediacy is the draw: the intervention happens in the moment. It's also the only platform of the two with FDA-cleared weight management claims and explicit GLP-1 medication support, which matters for the growing group monitoring glucose alongside Ozempic, Wegovy, or Mounjaro.

Both are built on established CGM sensor hardware (Nutrisense uses Abbott Libre), so treat readings the same way with either: good for trends and meal responses, not laboratory precision, in non-diabetic use.

On cost and commitment: Nutrisense runs $225–399/month; Signos runs $199–399/month with a 3-month minimum, so a Signos trial realistically totals $600–1,200 before you can walk away. One more honest note that applies to both: many users identify their main food triggers within a few months, after which continuous monitoring hits diminishing returns.

Choose Signos if weight loss or body composition is your primary goal, you respond well to real-time AI prompts, or you're on a GLP-1 medication and want glucose monitoring built around that context.

Choose Nutrisense if you want a human dietitian interpreting your data, your goals are broader than weight (energy, blood sugar habits, metabolic education), or you're a first-time CGM user who'd benefit from structured expert onboarding.

Think twice about both if you've already identified your food triggers from previous CGM use — continuous monitoring adds less at that stage — or if a multi-hundred-dollar monthly commitment strains the budget, in which case a ~$99/month OTC sensor is the saner experiment.

Both are legitimate, well-built platforms; they've simply specialized differently. Match the tool to the goal — human coaching for broad metabolic health, AI-driven and FDA-cleared programming for weight loss — and you're unlikely to regret either.